scholarly journals A Randomized Controlled Trial to Prevent Depression and Ameliorate Insulin Resistance in Adolescent Girls at Risk for Type 2 Diabetes

2016 ◽  
Vol 50 (5) ◽  
pp. 762-774 ◽  
Author(s):  
Lauren B. Shomaker ◽  
Nichole R. Kelly ◽  
Courtney K. Pickworth ◽  
Omni L. Cassidy ◽  
Rachel M. Radin ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Type 2 Diabetes ◽  
At Risk ◽  
Randomized Controlled Trial ◽  
Adolescent Girls ◽  
Controlled Trial ◽  
Randomized Controlled ◽  
Ameliorate Insulin Resistance

scholarly journals Digital Health Coaching for Type 2 Diabetes: Randomized Controlled Trial of Healthy at Home

2021 ◽  
Vol 3 ◽  
Author(s):  
Kimberly R. Azelton ◽  
Aidan P. Crowley ◽  
Nicholas Vence ◽  
Karin Underwood ◽  
Gerald Morris ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Digital Health ◽  
Controlled Trial ◽  
Health Coaching ◽  
Effective Control ◽  
Randomized Controlled ◽  
At Home

Digital health coaching is an intervention for type 2 diabetes mellitus (T2DM) that has potential to improve the quality of care for patients. Previous research has established the efficacy of digital interventions for behavior change. This pilot study addresses a research gap in finding effective and accessible behavioral interventions for under-resourced individuals with T2DM. We examined the impact of Healthy at Home, a 12-week phone and SMS-based (short message service) digital health coaching program, on insulin resistance which is an upstream marker for T2DM progression. We compared this intervention to usual diabetic care in a family medicine residency clinic in a randomized controlled trial. Digital health coaching significantly improved participants' calculated Homeostatic Model Assessment for Insulin Resistance (HOMA2-IR) by −0.9 ± 0.4 compared with the control group (p = 0.029). This significance remained after controlling for years diagnosed with T2DM, enrollment in Medicaid, access to food, baseline stage of change, and race (p = 0.027). Increasing access to digital health coaching may lead to more effective control of diabetes for under-resourced patients. This study demonstrates the potential to implement a personalized, scalable, and effective digital health intervention to treat and manage T2DM through a lifestyle and behavioral approach to improve clinical outcomes (http://clinicaltrials.gov, NCT04872647).

1126-P: Randomized Controlled Trial of Ipragliflozin or Sitagliptin Combined with Metformin in Type 2 Diabetes: NISM Study

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1126-P
Author(s):  
MASARU KITAZAWA ◽  
TAKASHI KATAGIRI ◽  
HIROMI SUZUKI ◽  
SATOSHI MATSUNAGA ◽  
MAYUKO H. YAMADA ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document